Navigation Links
TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
Date:5/23/2012

PLEASANTON, Calif., May 23, 2012 /PRNewswire/ -- TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug Administration (FDA) of the Glider™ PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.

Glider™ is the world's only torqueable PTCA balloon catheter. Combined with its state of the art tip technology, Glider™ is designed to perform, even in the most challenging conditions. It is also available in an ultra short balloon length of 4mm designed for focal lesions.

In a related piece of news, William L. Lombardi, MD of PeaceHealth St. Joseph Medical Center, Bellingham, WA performed the first case using Glider in the United States. "I was able to successfully use Glider to dilate a focal side branch lesion in a complex case and achieve a great outcome without the use of kissing balloons," stated Dr. Lombardi. "I am delighted to be the first Glider user in the US and believe that Glider presents a new and effective way of navigating through complex lesions."

"There has been very little innovation in balloons and catheter technology in the past decade and TriReme's innovative portfolio stands out," said James Hermiller, MD, director of the Interventional Fellowship at St. Vincent Heart Center of Indiana in Indianapolis. He added: "The newly approved ultra short balloon may be very useful for focal lesions and side branches. Combined with its crossing ability and the stable shaft, I can see it becoming a key tool in these types of cases."

"Glider is the latest addition to our portfolio of innovative PTA and PTCA devices that also includes the GliderXtreme™, GliderfleX® and Chocolate™", said Eitan Konstantino, Ph.D., President and Chief Executive Officer of TMI. "Those products are approved in the US and we are well underway to start getting approvals in our key targeted markets of Japan and China."

About TriReme Medical, Inc.
Based in Pleasanton, California and Singapore, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
2. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
3. TriReme Medical Announces $17 Million Series D Financing
4. TriReme Medical Announces Japanese Alliance
5. TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members
6. TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter
7. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
8. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
9. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
10. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... April 21, 2017 Halo Labs announces the ... particle analysis system called the Horizon at PEGS 2017 ... The new system analyzes sub visible particulate matter in ... particle screening as early as candidate selection and pre-formulation. ... biopharma contract research organization Elion Labs for ...
(Date:4/20/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... that it will be participating in the Deutsche Bank ... Hotel in Boston, Massachusetts on ... 11:20 a.m. Eastern Time. A live webcast ... Investor Relations website at http://investor.zimmerbiomet.com .  The webcast ...
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
Breaking Medicine Technology:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American ... pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in a ...
(Date:4/24/2017)... Boulder, CO (PRWEB) , ... April 24, 2017 ... ... 2017 American Educational Research Association’s Outstanding Public Communication of Education Research Award. The ... the public, including education communities. It recognizes a scholar who has demonstrated the ...
(Date:4/24/2017)... ... ... Veteran Theresa James awoke to the sound of her newly ex-husband breaking into ... depicts every parent’s worst nightmare, when her three children were violently taken from her. ... my divorce,” James said. “After the death of my children, I continued to journal. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick Care, a ... hours a day, Quick Care provides patients with the option to request and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Rod Burkett, CEO of Gardant Management Solutions, ... Rod has been at the forefront of Gardant since it was founded in 1999. ... overseen the opening of more than 40 new senior living communities. With his leadership, ...
Breaking Medicine News(10 mins):